Safety and efficacy of Pimecrolimus in atopic dermatitis among Chinese infants: a sub-group analysis of a five-year open-label study.
J Dermatolog Treat
; 34(1): 2229464, 2023 Dec.
Article
in En
| MEDLINE
| ID: mdl-37394952
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tacrolimus
/
Dermatitis, Atopic
/
Dermatologic Agents
Type of study:
Clinical_trials
Limits:
Humans
/
Infant
Language:
En
Journal:
J Dermatolog Treat
Journal subject:
DERMATOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: